CHRONIC LYMPHOCYTIC LEUKAEMIA: SAVE THE DATE #ESHCLL2022

ESH 2nd Translational Research Conference
CHRONIC LYMPHOCYTIC LEUKAEMIA

March 18-20, 2022
Paris, France
#ESHCLL2022

---

The programme is already available:

STAY TUNED: REGISTRATION OPENING SOON
Looking forward to meeting you face to face in Paris!

---

About the Conference:

The 2nd ESH TRANSLATIONAL RESEARCH CONFERENCE ON CHRONIC LYMPHOCYTIC LEUKAEMIA proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in Chronic Lymphocytic Leukaemia (CLL) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behaviour of the disease.

New data will be presented and spirited debates on how to best apply these insights to the future of CLL therapy are expected.

Emphasis will be placed on critical discussion, including in small groups. Further to the plenary sessions, the programme includes informal thematic break-out sessions and mentored poster walks.

---

CONFERENCE MAIN TOPICS:

• Genomic and Epigenomic Landscape of CLL
• Role of BCR Activation and Signalling in CLL
• Role of the Leukemic Microenvironment
• Updates on Therapeutic Options, from Clinical Trials and Real World Experience
• Therapeutic Resistance
• Considerations for the Future of CLL Therapy

For more information, click here!

---